Home›Companies›Biotech & Pharma›Canal Biosciences

Canal Biosciences, Inc.

DNA preparation kits for researchers who sequence DNA.

No LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Apr 13, 2026·Suggest an edit

About Canal Biosciences

Canal Biosciences is a private company based in Lowell, Massachusetts, incorporated in 2024 in Delaware. It has reported $2,334,997 raised in one offering on Form D since April 2026. Its chief executive is Christopher Benoit.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 18, 2026Apr 13, 2026$2,334,997of $3.2M target18$129KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Canal Biosciences's Form D filed Apr 13, 2026.

Christopher Benoit
Christopher Benoit
Co-CEO and director
Also a chief executive officer and director at TwinStrand Biosciences.
Yu Zheng
Yu Zheng
Founder & Co-CEO, director

Sources

  1. SECCanal Biosciences, Inc. filing history
  2. CompanyContact Canal Biosciences